← Back to Clinical Trials
Recruiting NCT07574151

NCT07574151 Accessing the Clarity and Acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease Surveillance

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07574151
Status Recruiting
Phase
Sponsor University of Nottingham
Condition Thoracic Aortic Disease
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2026-03-11
Primary Completion 2026-07-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Acceptability and Clarity

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2026-03-11 with a primary completion date of 2026-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

People who are invited to take part in health research are usually given written information, such as invitation letters, and information sheets. These documents are essential because they help people understand what the study involves and decide whether they want to take part. However, many studies have shown that research information is often too complex, too long, or written in technical language. This can make it difficult for people to fully understand the study and give informed consent. This study aims to assess how clear, accessible, and acceptable draft research documents are for a proposed future doctoral study related to thoracic aortic disease. Thoracic aortic disease is a long-term condition that requires regular monitoring, and people in surveillance programmes may be invited to take part in research. It is therefore important that study information is clear, sensitive, and easy to understand. In this study, staff and students from the University's School of Health Sciences will be asked to review draft recruitment materials. These materials include a study invitation, an information sheet, and interview guide. Participants will be asked to give feedback on how easy the documents are to read, whether the information is clear, whether the tone feels appropriate, and whether the amount of information feels reasonable. The study will also use a standard readability tool to assess whether the documents are written at a level suitable for the public. This research does not involve patients and is considered low risk. Its purpose is to improve research materials before they are used with patients, helping to support informed consent, reduce confusion, and improve ethical and inclusive research practice in future studies.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years or older * Able to read and understand English Exclusion Criteria: * Individuals under 18 * Individuals unable to provide informed consent * Individuals unable to read or understand English

Contact & Investigator

Central Contact

Charles B Mensah, MA Research Methods- Health

✉ ntxcm25@nottingham.ac.uk

📞 +44

Principal Investigator

Charles B Mensah, MA Research Methods -Health

STUDY DIRECTOR

University of Nottingham

Frequently Asked Questions

Who can join the NCT07574151 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Thoracic Aortic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07574151 currently recruiting?

Yes, NCT07574151 is actively recruiting participants. Contact the research team at ntxcm25@nottingham.ac.uk for enrollment information.

Where is the NCT07574151 trial being conducted?

This trial is being conducted at Nottingham, United Kingdom.

Who is sponsoring the NCT07574151 clinical trial?

NCT07574151 is sponsored by University of Nottingham. The principal investigator is Charles B Mensah, MA Research Methods -Health at University of Nottingham. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology